O. Trabelsi Grati

Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies.

C. Béroud, I. Soubeyran, L. Miguet, 2021, European journal of cancer.

Long response to immune checkpoint inhibitors in metastatic NSCLC despite EGFR germline mutation. A case report.

I. Bièche, C. Callens, S. Melaabi, 2022, Lung cancer.

Tumor BRCA testing can reveal a high tumor mutational burden related to POLE pathogenic variants

A. Vincent-Salomon, I. Bièche, D. Stoppa-Lyonnet, 2021, Gynecologic oncology reports.

Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis.

S. Vacher, S. Taillibert, O. Trédan, 2022, Neuro-oncology.